Legal Representation
Attorney
Carol H. Peters
USPTO Deadlines
Application History
8 events| Date | Code | Type | Description |
|---|---|---|---|
| Oct 7, 2020 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Oct 7, 2020 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Mar 26, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Mar 26, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Mar 26, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 17, 2020 | DOCK | D | ASSIGNED TO EXAMINER |
| Dec 23, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Dec 21, 2019 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Scientific research, development, and testing services featuring cloud-based, scientific cognitive computing and simulation platforms using artificial intelligence and data for testing scientific empirical queries, generating and testing hypotheses and formulating responses, screening, modeling, and simulating biological and molecular processes and pathways, simulating and automating experimentation and testing, and generating data and contextual analyses and predictive models, all of the aforementioned in the fields of new drug screening and discovery, new drug development, drug improvement, and clinical testing of drugs; Cloud computer services featuring cloud-based, scientific cognitive computing and simulation platforms using artificial intelligence and data for testing scientific empirical queries, generating and testing hypotheses and formulating responses, screening, modeling, and simulating biological and molecular processes and pathways, simulating and automating experimentation and testing, and generating data and contextual analyses and predictive models, all of the aforementioned in the fields of new drug screening and discovery, new drug development, drug improvement, and clinical testing of drugs; and Platform as a service (PAAS) featuring cloud-based, scientific cognitive computing and simulation platforms using artificial intelligence and data for testing scientific empirical queries, generating and testing hypotheses and formulating responses, screening, modeling, and simulating biological and molecular processes and pathways, simulating and automating experimentation and testing, and generating data and contextual analyses and predictive models, all of the aforementioned in the fields of new drug screening and discovery, new drug development, drug improvement, and clinical testing of drugs
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
042